| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Laboratory of Cerebral Metabolism, National Institute of Mental Health (T.E., M.C., L.S., J.N.); Positron Emission Department, Clinical Center (K.S.); and Laboratory of Molecular Biology, National Cancer Institute (H.S., S.-Y.C.), National Institutes of Health, Bethesda, Maryland 20892
Address requests for reprints to: Dr. Louis Sokoloff, Laboratory of Cerebral Metabolism, National Institute of Mental Health, Building 36, Room 1A-07, 36 Convent Drive, MSC 4030, Bethesda, Maryland 20892. E-mail: louis{at}shiloh.nimh.nih.gov.
Neonatal hypothyroidism impairs structural maturation in the brain and results in diminished electrical activities and energy metabolism. We recently found that glucose utilization (CMRglc) is markedly depressed throughout the brain in mice with targeted mutations in thyroid hormone receptor
1 (TR
1), but not TRß. Previous studies had shown that CMRglc increases linearly with spike frequency in the afferent pathways to synapse-rich regions in neuropil, but not in neuronal cell bodies. To determine whether the decreased CMRglc in mutant TR
1PV/+ mice reflected lesser synaptic density or reduced functional activity in existing synapses, we stimulated vibrissae unilaterally and measured CMRglc bilaterally in four stations of the whisker-to-barrel cortex pathway. Baseline CMRglc (unstimulated side) was markedly lower in all four stations in the TR
1PV/+ mutants than in wild-type controls, even though Northern blot and immunohistochemical examinations showed normal Na+,K+-adenosine triphosphatase expression and neuronal differentiation. Despite the lower baseline CMRglc, however, vibrissal stimulation evoked percent increases in CMRglc in the TR
1PV/+ mutants that were as great as those in wild-type mice. These results indicate that in the TR
1PV/+ mutants there it is a reduction in synaptic density that is responsible for the decrease in CMRglc, but functionality of existing synapses is retained.
This article has been cited by other articles:
![]() |
L. Quignodon, S. Vincent, H. Winter, J. Samarut, and F. Flamant A Point Mutation in the Activation Function 2 Domain of Thyroid Hormone Receptor {alpha}1 Expressed after CRE-Mediated Recombination Partially Recapitulates Hypothyroidism Mol. Endocrinol., October 1, 2007; 21(10): 2350 - 2360. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Esaki, M. Cook, K. Shimoji, D. L. Murphy, L. Sokoloff, and A. Holmes Developmental disruption of serotonin transporter function impairs cerebral responses to whisker stimulation in mice PNAS, April 12, 2005; 102(15): 5582 - 5587. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Alkemade, C. L. Vuijst, U. A. Unmehopa, O. Bakker, B. Vennstrom, W. M. Wiersinga, D. F. Swaab, and E. Fliers Thyroid Hormone Receptor Expression in the Human Hypothalamus and Anterior Pituitary J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 904 - 912. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |